TNF, JAK Inhibitors ' CV Safety Compared in PsA, AxSpA TNF, JAK Inhibitors ' CV Safety Compared in PsA, AxSpA

JAK inhibitors were not associated with higher risk of myocardial infarction or stroke and venous thromboembolism, compared with TNF-inhibitor users, in a small study.MDedge News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Rheumatology News Source Type: news